St Jude Medical Inc (STJ)

80.82
0.13 0.16
NYSE : Health Care
Prev Close 80.69
Open 80.80
Day Low/High 80.72 / 81.31
52 Wk Low/High 48.83 / 84.00
Volume 14.74M
Avg Volume 2.67M
Exchange NYSE
Shares Outstanding 285.72M
Market Cap 23.09B
EPS 3.10
P/E Ratio 35.39
Div & Yield 1.24 (1.50%)
St. Jude Medical Still a Buy Despite Product Concerns

St. Jude Medical Still a Buy Despite Product Concerns

St. Jude shares deserve to be higher ahead of the merger with Abbott Labs. Here's why.

Jim Cramer: Drug Stocks Feeling Political Pressure

Jim Cramer: Drug Stocks Feeling Political Pressure

Political pressure is weighing on drug and medical device stocks including Abbott Labs and St. Jude, says Jim Cramer.

Abbott CEO Is Unfazed by Muddy Waters' Attack on St. Jude

Abbott CEO Is Unfazed by Muddy Waters' Attack on St. Jude

Miles White also reiterated that Abbott Laboratories has no plans to divest of its diabetes business. He still believes in Alere over the long term.

St. Jude Spars With Muddy Waters After Earnings Miss

St. Jude Spars With Muddy Waters After Earnings Miss

The medical device maker responded to allegations that its devices could be hacked during its third quarter earnings call.

St. Jude Medical (STJ) Stock Slips, Q3 Earnings Miss Estimates

St. Jude Medical (STJ) Stock Slips, Q3 Earnings Miss Estimates

St. Jude Medical (STJ) reported earnings that fell short of Wall Street's projections on Wednesday.

St. Jude Medical Reports Third Quarter 2016 Results

St. Jude Medical Reports Third Quarter 2016 Results

St. Jude Medical, Inc.

Abbott, St. Jude Float Antitrust Spinoff by FTC

Abbott, St. Jude Float Antitrust Spinoff by FTC

They plan to sell portions of their vascular closure and electrophysiology businesses to Japan's Terumo Corp. for $1.12 billion.

What to Look For When St. Jude Medical (STJ) Reports Q3 Earnings

What to Look For When St. Jude Medical (STJ) Reports Q3 Earnings

Analysts are expecting St. Jude Medical's (STJ) 2016 third-quarter earnings and revenue to rise year-over-year.

What to Watch on Wall Street This Week: Netflix Earnings, Fed Speakers

What to Watch on Wall Street This Week: Netflix Earnings, Fed Speakers

Investors will get a slew of earnings reports from major companies and a host of Federal Reserve speakers during the week of Oct. 17.

Illumina Leads Healthcare Selloff, Abbott and Zimmer Also Fall

Illumina Leads Healthcare Selloff, Abbott and Zimmer Also Fall

Illumina fell 24% on news that it was cutting revenue guidance.

Closing Bell: FCC Hits Comcast With Fine; U.S. Stocks Sell Off

Closing Bell: FCC Hits Comcast With Fine; U.S. Stocks Sell Off

U.S. stocks bottom out during Tuesday afternoon's session as a disappointing quarterly performance from Alcoa heralds a poor start to the third-quarter earnings season.

St. Jude (STJ) Stock Falls on Defibrillator Concerns

St. Jude (STJ) Stock Falls on Defibrillator Concerns

St. Jude's (STJ) issue with batteries in its implanted heart devices is unlikely to spiral into a bigger problem, Cowen & Co. says.

Cramer: Sing It, Martha -- Nowhere to Run to in This Market, Nowhere to Hide

Cramer: Sing It, Martha -- Nowhere to Run to in This Market, Nowhere to Hide

On days like this, the money just keeps sloshing around.

St. Jude Shares Slip on Defibrillator Battery Warning

St. Jude Shares Slip on Defibrillator Battery Warning

Many investors were exiting their investments in the medical-device giant on news of the warning.

Jim Cramer: St. Jude Battery Woes Big But Not a Dealbreaker

Jim Cramer: St. Jude Battery Woes Big But Not a Dealbreaker

St. Jude's warning about battery risks in its implanted heart devices are big but will likely not disrupt its deal with Abbott Labs.

St. Jude Device Failures Won't Ruin Abbott Deal

St. Jude Device Failures Won't Ruin Abbott Deal

St. Jude Medical's defibrillators are having problems with batteries, but this likely won't affect Abbott Laboratories' acquisition of the medical device maker.

Jim Cramer -- Will St. Jude Product Alert Affect Abbott's Offer?

Jim Cramer -- Will St. Jude Product Alert Affect Abbott's Offer?

Abbott agreed to acquire St. Jude Medical for $25 billion, or about $85 per share. But with an alert on a major St. Jude product, what now? Cramer wonders.

Morning Movers: ILMN, STJ, AA, MRO, CHK

Morning Movers: ILMN, STJ, AA, MRO, CHK

Shares of Illumina were tanking before the opening bell after unveiling a disappointing sales forecast.

St. Jude (STJ) Stock Falls on Defibrillator Battery Warning

St. Jude (STJ) Stock Falls on Defibrillator Battery Warning

St. Jude (STJ) said that batteries within its implanted heart devices could unexpectedly deplete.

St. Jude Medical PressureWire™ X Guidewire (Photo: Business Wire)

St. Jude Medical PressureWire™ X Guidewire (Photo: Business Wire)

St. Jude Medical, Inc.

The St. Jude Medical Infinity™ DBS System (Photo: Business Wire)

The St. Jude Medical Infinity™ DBS System (Photo: Business Wire)

St. Jude Medical, Inc.

St. Jude Medical Announces Third Quarter 2016 Earnings Conference Call

St. Jude Medical Announces Third Quarter 2016 Earnings Conference Call

St. Jude Medical, Inc.

Vigorous M&A Activity Signals Economic Health

Vigorous M&A Activity Signals Economic Health

Despite markets at record highs, companies are satisfying their appetites to grow and find value by buying others.

Mediation Talks Between Abbott and Alere Collapse

Mediation Talks Between Abbott and Alere Collapse

Health care companies will likely continue their battle over a soured merger in Delaware court.

St Jude Medical Becomes #201 Most Shorted S&P 500 Component, Replacing Jacobs Engineering Group

St Jude Medical Becomes #201 Most Shorted S&P 500 Component, Replacing Jacobs Engineering Group

The most recent short interest data has been released for the 09/15/2016 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

4 Market Segments to Avoid

4 Market Segments to Avoid

These sectors are full of high-priced, low-growth stocks.